Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOMP maintenance olaparib trial in small cell lung cancer
2010-021165-76Phase 2Unknown
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in small cell lung cancer (SCLC) comparing Olaparib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Status: unknown.
02
Drugs
olaparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2010-021165-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021165-76.